1
|
Haseli S, Mansoori B, Shafiei M, Shomal Zadeh F, Chalian H, Khoshpouri P, Yousem D, Chalian M. A Review of Posteromedial Lesions of the Chest Wall: What Should a Chest Radiologist Know? Diagnostics (Basel) 2022; 12:diagnostics12020301. [PMID: 35204391 PMCID: PMC8871555 DOI: 10.3390/diagnostics12020301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2021] [Revised: 01/11/2022] [Accepted: 01/20/2022] [Indexed: 12/10/2022] Open
Abstract
A heterogeneous group of tumors can affect the posteromedial chest wall. They form diverse groups of benign and malignant (primary or secondary) pathologies that can arise from different chest wall structures, i.e., fat, muscular, vascular, osseous, or neurogenic tissues. Chest radiography is very nonspecific for the characterization of chest wall lesions. The modality of choice for the initial assessment of the chest wall lesions is computed tomography (CT). More advanced cross-sectional modalities such as magnetic resonance imaging (MRI) and positron emission tomography (PET) with fluorodeoxyglucose are usually used for further characterization, staging, treatment response, and assessment of recurrence. A systematic approach based on age, clinical history, and radiologic findings is required for correct diagnosis. It is essential for radiologists to be familiar with the spectrum of lesions that might affect the posteromedial chest wall and their characteristic imaging features. Although the imaging findings of these tumors can be nonspecific, cross-sectional imaging helps to limit the differential diagnosis and determine the further diagnostic investigation (e.g., image-guided biopsy). Specific imaging findings, e.g., location, mineralization, enhancement pattern, and local invasion, occasionally allow a particular diagnosis. This article reviews the posteromedial chest wall anatomy and different pathologies. We provide a combination of location and imaging features of each pathology. We will also explore the role of imaging and its strengths and limitations for diagnosing posteromedial chest wall lesions.
Collapse
Affiliation(s)
- Sara Haseli
- Department of Radiology, Division of Musculoskeletal Imaging and Intervention, University of Washington, Seattle, WA 98105, USA; (S.H.); (M.S.); (F.S.Z.); (P.K.)
| | - Bahar Mansoori
- Department of Radiology, Division of Abdominal Imaging, University of Washington, Seattle, WA 98105, USA;
| | - Mehrzad Shafiei
- Department of Radiology, Division of Musculoskeletal Imaging and Intervention, University of Washington, Seattle, WA 98105, USA; (S.H.); (M.S.); (F.S.Z.); (P.K.)
| | - Firoozeh Shomal Zadeh
- Department of Radiology, Division of Musculoskeletal Imaging and Intervention, University of Washington, Seattle, WA 98105, USA; (S.H.); (M.S.); (F.S.Z.); (P.K.)
| | - Hamid Chalian
- Department of Radiology, Division of Cardiothoracic Imaging, University of Washington, Seattle, WA 98105, USA;
| | - Parisa Khoshpouri
- Department of Radiology, Division of Musculoskeletal Imaging and Intervention, University of Washington, Seattle, WA 98105, USA; (S.H.); (M.S.); (F.S.Z.); (P.K.)
| | - David Yousem
- Russell H. Morgan Department of Radiology and Radiological Sciences, Division of Neuroradiology, Johns Hopkins Medical Center, Baltimore, MD 21287, USA;
| | - Majid Chalian
- Department of Radiology, Division of Musculoskeletal Imaging and Intervention, University of Washington, Seattle, WA 98105, USA; (S.H.); (M.S.); (F.S.Z.); (P.K.)
- Correspondence: ; Tel.: +1+(206)-598-2405
| |
Collapse
|
2
|
Empyema Necessitans due to Interruption of Antituberculosis Treatment. Case Rep Infect Dis 2019; 2019:4810354. [PMID: 31275673 PMCID: PMC6560332 DOI: 10.1155/2019/4810354] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2019] [Revised: 03/16/2019] [Accepted: 04/08/2019] [Indexed: 11/17/2022] Open
Abstract
Empyema necessitans is a rare presentation of tuberculous infection, commonly encountered in immunocompromised patients. The diagnosis can be challenging due to the paucibacillary nature of the condition and nonspecific symptoms. Identifying the organism in culture is the gold standard method of diagnosis. We describe a patient with chronic kidney disease, who developed empyema necessitans due to interruption of antituberculous therapy. Initially, he was started on antituberculous therapy based on a clinical diagnosis of smear-negative pulmonary tuberculous infection; this resulted in Stevens–Johnson syndrome needing a long course of steroid therapy. He later presented with a painful chest lump and was diagnosed as empyema necessitans. Finding the etiology for this rare presentation lead to a diagnostic dilemma, finally confirming the TB infection from the culture. This case highlights the importance of being aware of unusual complications of tuberculous infection in immunocompromised settings.
Collapse
|